drugset / Trial / NCT00002590

Combination Chemotherapy in Treating Children With Lymphoma

NCT00002590 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children who have lymphoma.

Timeline

Start
1994-07
Primary completion
2001-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule — —
Subject Etoposide Small molecule — —
Subject Methotrexate Small molecule — —
Subject Pegaspargase Protein / enzyme biologic — —
Background Cyclophosphamide Other / unclassified — —
Background Daunorubicin Small molecule — —
Background Doxorubicin Other / unclassified — —
Background Leucovorin Small molecule — —
Background Prednisone Other / unclassified — —
Background Thioguanine Small molecule — —
Background Vincristine Small molecule — —
Background filgrastim Protein / enzyme biologic — —

Indications